Symbol
Y-mAbs Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$4.66
Current price of the stock
$823K
Trading volume of the stock
$208.0M
Market capitalization of the company
Micro Cap
Category of market capitalization
26.95%
Long-term growth mean estimate
4.53
Mean analyst rating
279.83%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
3.92
Current ratio
87.82%
Gross profit margin
-46.41%
Operating profit margin
-46.41%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-36.03%
Pretax profit margin
-37.91%
Net profit margin
-7.57%
Measures profitability relative to shareholders' equity
-7.77%
ROE excluding intangible assets
-5.79%
Measures profitability relative to total assets
-7.57%
Measures profitability relative to invested capital
0.15
Asset turnover ratio
0.24
Inventory turnover ratio
0.93
Receivables turnover ratio
97.09
Average number of days it takes to collect receivables
-8.63
Measures valuation relative to earnings
-7.64
P/E based on future earnings estimates
2.46
Measures valuation relative to sales
2.26
Measures valuation relative to book value
-4.29
Measures valuation relative to operating cash flow
-4.29
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
